JP2007532638A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007532638A5 JP2007532638A5 JP2007508301A JP2007508301A JP2007532638A5 JP 2007532638 A5 JP2007532638 A5 JP 2007532638A5 JP 2007508301 A JP2007508301 A JP 2007508301A JP 2007508301 A JP2007508301 A JP 2007508301A JP 2007532638 A5 JP2007532638 A5 JP 2007532638A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- substituted
- acid
- halogen
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims 30
- 229910052736 halogen Inorganic materials 0.000 claims 17
- 150000002367 halogens Chemical class 0.000 claims 12
- 229910052739 hydrogen Inorganic materials 0.000 claims 12
- 125000003545 alkoxy group Chemical group 0.000 claims 11
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 9
- 125000003342 alkenyl group Chemical group 0.000 claims 8
- 125000000623 heterocyclic group Chemical group 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- 125000001589 carboacyl group Chemical group 0.000 claims 6
- 238000001727 in vivo Methods 0.000 claims 6
- 239000002243 precursor Substances 0.000 claims 6
- 230000008485 antagonism Effects 0.000 claims 5
- 230000009286 beneficial effect Effects 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 125000001624 naphthyl group Chemical group 0.000 claims 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- 125000003277 amino group Chemical group 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 2
- 206010034912 Phobia Diseases 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- 206010036618 Premenstrual syndrome Diseases 0.000 claims 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 150000007522 mineralic acids Chemical class 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 150000007524 organic acids Chemical class 0.000 claims 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims 2
- 125000005329 tetralinyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 claims 2
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 claims 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims 1
- 206010008025 Cerebellar ataxia Diseases 0.000 claims 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 claims 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 1
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 1
- 208000011688 Generalised anxiety disease Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 201000009916 Postpartum depression Diseases 0.000 claims 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 claims 1
- 206010041250 Social phobia Diseases 0.000 claims 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims 1
- 206010046543 Urinary incontinence Diseases 0.000 claims 1
- 235000011054 acetic acid Nutrition 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 150000001450 anions Chemical class 0.000 claims 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims 1
- 229940092714 benzenesulfonic acid Drugs 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 235000015165 citric acid Nutrition 0.000 claims 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 claims 1
- 239000001530 fumaric acid Substances 0.000 claims 1
- 208000029364 generalized anxiety disease Diseases 0.000 claims 1
- 208000031424 hyperprolactinemia Diseases 0.000 claims 1
- 208000021267 infertility disease Diseases 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 208000024714 major depressive disease Diseases 0.000 claims 1
- 229940098779 methanesulfonic acid Drugs 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 claims 1
- 208000019906 panic disease Diseases 0.000 claims 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims 1
- 208000022821 personality disease Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 208000019899 phobic disease Diseases 0.000 claims 1
- 201000000484 premenstrual tension Diseases 0.000 claims 1
- 230000000306 recurrent effect Effects 0.000 claims 1
- 229960004889 salicylic acid Drugs 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
- 230000001568 sexual effect Effects 0.000 claims 1
- 201000001716 specific phobia Diseases 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 239000011975 tartaric acid Substances 0.000 claims 1
- 235000002906 tartaric acid Nutrition 0.000 claims 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- PVOAHINGSUIXLS-UHFFFAOYSA-N CN1CCNCC1 Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- SJRJJKPEHAURKC-UHFFFAOYSA-N CN1CCOCC1 Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0400969A SE0400969D0 (sv) | 2004-04-14 | 2004-04-14 | Aryl glycine derivatives and their use |
| SE0400967A SE0400967D0 (sv) | 2004-04-14 | 2004-04-14 | Aryl glycinamide derivatives and their use |
| PCT/SE2005/000501 WO2005100325A1 (en) | 2004-04-14 | 2005-04-06 | Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007532638A JP2007532638A (ja) | 2007-11-15 |
| JP2007532638A5 true JP2007532638A5 (https=) | 2008-05-29 |
Family
ID=35149928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007508301A Pending JP2007532638A (ja) | 2004-04-14 | 2005-04-06 | Ｎｋ１アンタゴニスト及びセロトニン再取り込み阻害剤としてのアリールグリシンアミド誘導体及びその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20070203139A1 (https=) |
| EP (1) | EP1740553A1 (https=) |
| JP (1) | JP2007532638A (https=) |
| WO (1) | WO2005100325A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100595963B1 (ko) * | 2004-04-13 | 2006-07-05 | 한국화학연구원 | 인덴 유도체 및 이의 제조방법 |
| WO2014181788A1 (ja) * | 2013-05-08 | 2014-11-13 | キッセイ薬品工業株式会社 | α－置換グリシンアミド誘導体 |
| WO2024121129A1 (en) * | 2022-12-05 | 2024-06-13 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2845293A1 (de) * | 1978-10-18 | 1980-05-08 | Basf Ag | Alpha -azolyl- alpha -phenylessigsaeurederivate |
| JPS5852256A (ja) * | 1981-09-24 | 1983-03-28 | Nippon Nohyaku Co Ltd | 置換又は非置換脂肪酸アミド誘導体及びその塩類 |
| CA2123403C (en) * | 1991-11-12 | 2002-02-05 | Brian T. O'neill | Acyclic ethylenediamine derivatives as substance p receptor antagonists |
| JPH05294915A (ja) * | 1992-04-21 | 1993-11-09 | Yamanouchi Pharmaceut Co Ltd | タキキニン拮抗剤 |
| JP3429338B2 (ja) * | 1992-07-27 | 2003-07-22 | 杏林製薬株式会社 | 新規なアリールグリシンアミド誘導体及びその製造法 |
| US5776983A (en) * | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
| FR2723739B1 (fr) * | 1994-08-19 | 1997-02-14 | Sanofi Sa | Derives de glycinamide, procedes pour leur preparation et medicaments les contenant. |
| US5696123A (en) * | 1994-09-17 | 1997-12-09 | Boehringer Ingelheim Kg | Neurokinin antagonists |
| TW449590B (en) * | 1995-04-14 | 2001-08-11 | Boehringer Ingelheim Kg | New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| DE19608665A1 (de) * | 1996-03-06 | 1997-09-11 | Boehringer Ingelheim Kg | Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
| DE19824470A1 (de) * | 1998-05-30 | 1999-12-02 | Boehringer Ingelheim Pharma | Neue Neurokininantagonisten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
| EP1033366A3 (en) * | 1999-02-18 | 2000-12-27 | Pfizer Products Inc. | Amide derivatives useful as Neuropeptide Y (NPY) antagonists |
| JP2004532834A (ja) * | 2001-03-23 | 2004-10-28 | イーライ・リリー・アンド・カンパニー | ヒスタミンｈ３受容体アンタゴニストである非イミダゾール系アリールアルキルアミン化合物、その製造および治療的使用 |
| US6946542B2 (en) * | 2002-04-01 | 2005-09-20 | University Of Southern California | Amino amides, peptides and peptidomimetics |
| DE10230750A1 (de) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkompositionen auf der Basis neuer Anticholonergika und NK1-Rezeptor-Antagonisten |
| GEP20084360B (en) * | 2004-02-04 | 2008-04-29 | Pfizer Prod Inc | Substituted quinoline compounds |
-
2005
- 2005-04-06 WO PCT/SE2005/000501 patent/WO2005100325A1/en not_active Ceased
- 2005-04-06 JP JP2007508301A patent/JP2007532638A/ja active Pending
- 2005-04-06 EP EP05730884A patent/EP1740553A1/en not_active Withdrawn
- 2005-04-06 US US10/599,823 patent/US20070203139A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7252908B2 (ja) | Ｓ１ｐ１活性を調節するための化合物およびその使用法 | |
| KR101714799B1 (ko) | 치환된 5,6-디히드로-6-페닐벤조［ｆ］이소퀴놀린-2-아민 화합물 | |
| JP6511430B2 (ja) | がんの治療のための化合物および組成物 | |
| JP6046710B2 (ja) | 置換されたイミダゾピリジニル−アミノピリジン化合物 | |
| US8580803B2 (en) | Substituted pyrrolo-aminopyrimidine compounds | |
| RU2619463C2 (ru) | Замещенные имидазопиридинил-аминопиридиновые соединения, полезные при лечении рака | |
| JP5825535B2 (ja) | Ｈｅｃ１活性の調節因子およびそのための方法 | |
| JP6054379B2 (ja) | キナーゼをモジュレートするための組成物および方法 | |
| US8541407B2 (en) | Substituted benzo-pyrido-triazolo-diazepine compounds | |
| CN110049987A (zh) | 制备(s)-n-(5-((r)-2-(2，5-二氟苯基)吡咯烷-1-基)-吡唑并[1，5-a]嘧啶-3-基)-3-羟基吡咯烷-1-甲酰胺及其盐的方法 | |
| AU2015349866A1 (en) | 4-oxo-3,4-dihydro-1,2,3-benzotriazines as modulators of GPR139 | |
| CN107074769A (zh) | 用于治疗增生性病症的组合物和方法 | |
| CN105143188B (zh) | 新型磺酰胺trpa1受体拮抗剂 | |
| TW201313710A (zh) | 經取代之咪唑並吡啶基化合物 | |
| TW201522337A (zh) | 經取代之三環吡唑並－嘧啶化合物類 | |
| JP2021535112A5 (https=) | ||
| EA037738B1 (ru) | Кристаллические формы ингибиторов глутаминазы | |
| US20070299083A1 (en) | 6-Methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts | |
| JP2008543782A (ja) | ５−ｈｔ１ａ受容体のピペラジン−ピペリジンアンタゴニストおよびアゴニスト | |
| SK12452003A3 (sk) | Derivát fenylheterocyklyléteru ako inhibítor reabsorpcie serotonínu, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje | |
| JP2007532638A5 (https=) | ||
| RU2007125659A (ru) | Фенилпиперазиновые производные с сочетанием свойств неполного агонизма к рецепторам дофамина-d2 и ингибирования повторного поглощения серотонина | |
| JP2007532636A5 (https=) | ||
| CN103864762B (zh) | 3,6-双（吡啶-4-基乙炔基）咔唑衍生物及其制备方法和应用 | |
| TWI525091B (zh) | 吡咯並喹啉基－吡咯啶－２，５－二酮組成物類及製備和使用彼等之方法 |